Finance

Beta
Lists
EWTX:NASDAQ
Edgewise Therapeutics Inc
$37.06
+2.36%
(+0.85) 1D
Jun 4, 9:48:56 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EWTX...
Open
$35.99
High
$37.14
Low
$35.99
Mkt. cap
4.00B
Avg. vol.
1.46M
Volume
15.36K
52-wk high
$40.76
52-wk low
$12.15
EPS
-$1.66
Beta
0.27
Shares outstanding
107.59M
No. of employees
154
Open
$35.99
High
$37.14
Low
$35.99
Mkt. cap
4.00B
Avg. vol.
1.46M
Volume
15.36K
52-wk high
$40.76
52-wk low
$12.15
EPS
-$1.66
Beta
0.27
Shares outstanding
107.59M
No. of employees
154
News stories
From sources across the web
About Edgewise Therapeutics Inc
CEO-
Employees154
Founded2017
HeadquartersBoulder, Colorado, United States
SectorPharmaceutical industry
Websiteedgewisetx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.46 / -$0.48
+3.72%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.56M
37.48M
43.59M
42.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.05M
9.38M
12.38M
11.46M
Operating expense
42.61M
46.86M
55.98M
54.12M
Total operating expenses
42.61M
46.86M
55.98M
54.12M
Operating income
-42.61M
-46.86M
-55.98M
-54.12M
Other non operating income
-
-
-
-
EBT including unusual items
-36.12M
-40.67M
-50.22M
-49.01M
EBT excluding unusual items
-36.12M
-40.67M
-50.22M
-49.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36.12M
-40.67M
-50.22M
-49.01M
Net profit margin
-
-
-
-
Earnings per share
-0.34
-0.39
-0.47
-0.46
Interest and investment income
6.50M
6.19M
5.76M
5.10M
Interest expense
-
-
-
-
Net interest expenses
6.50M
6.19M
5.76M
5.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.09M
-46.34M
-55.45M
-53.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer